252 related articles for article (PubMed ID: 12147717)
1. Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.
Le Rouzic E; Thoraval P; Afanassieff M; Cherel Y; Dambrine G; Perbal B
Mol Pathol; 2002 Aug; 55(4):262-72. PubMed ID: 12147717
[TBL] [Abstract][Full Text] [Related]
2. Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line.
Le Rouzic E; Perbal B
J Virol; 1996 Nov; 70(11):7414-23. PubMed ID: 8892859
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV.
Peng Q; Zeng M; Bhuiyan ZA; Ubukata E; Tanaka A; Nonoyama M; Shirazi Y
Virology; 1995 Nov; 213(2):590-9. PubMed ID: 7491783
[TBL] [Abstract][Full Text] [Related]
4. Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells.
Xie Q; Anderson AS; Morgan RW
J Virol; 1996 Feb; 70(2):1125-31. PubMed ID: 8551572
[TBL] [Abstract][Full Text] [Related]
5. Role of Marek's Disease Virus (MDV)-Encoded U
Liao Y; Lupiani B; Bajwa K; Khan OA; Izumiya Y; Reddy SM
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581093
[TBL] [Abstract][Full Text] [Related]
6. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
[TBL] [Abstract][Full Text] [Related]
7. Induction of DNA Damages upon Marek's Disease Virus Infection: Implication in Viral Replication and Pathogenesis.
Bencherit D; Remy S; Le Vern Y; Vychodil T; Bertzbach LD; Kaufer BB; Denesvre C; Trapp-Fragnet L
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978699
[TBL] [Abstract][Full Text] [Related]
8. Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript.
Burnside J; Bernberg E; Anderson A; Lu C; Meyers BC; Green PJ; Jain N; Isaacs G; Morgan RW
J Virol; 2006 Sep; 80(17):8778-86. PubMed ID: 16912324
[TBL] [Abstract][Full Text] [Related]
9. Latency and tumorigenesis in Marek's disease.
Nair V
Avian Dis; 2013 Jun; 57(2 Suppl):360-5. PubMed ID: 23901747
[TBL] [Abstract][Full Text] [Related]
10. Evidence that Marek's disease virus exists in a latent state in a sustainable fibroblast cell line.
Abujoub AA; Coussens PM
Virology; 1997 Mar; 229(2):309-21. PubMed ID: 9126245
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
12. Marek's disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene.
Cantello JL; Parcells MS; Anderson AS; Morgan RW
J Virol; 1997 Feb; 71(2):1353-61. PubMed ID: 8995659
[TBL] [Abstract][Full Text] [Related]
13. Coinfection of specific-pathogen-free chickens with Marek's disease virus (MDV) and chicken infectious anemia virus: effect of MDV pathotype.
Miles AM; Reddy SM; Morgan RW
Avian Dis; 2001; 45(1):9-18. PubMed ID: 11332504
[TBL] [Abstract][Full Text] [Related]
14. Marek's disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas.
Ross N; O'Sullivan G; Rothwell C; Smith G; Burgess SC; Rennie M; Lee LF; Davison TF
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2191-8. PubMed ID: 9292006
[TBL] [Abstract][Full Text] [Related]
15. Targeted Deletion of Glycoprotein B Gene by CRISPR/Cas9 Nuclease Inhibits
Zhang Y; Li W; Tang N; Moffat K; Nair V; Yao Y
J Virol; 2022 Mar; 96(6):e0202721. PubMed ID: 35107377
[TBL] [Abstract][Full Text] [Related]
16. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
Omar AR; Schat KA
Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
[TBL] [Abstract][Full Text] [Related]
17. The Marek's Disease Virus Unique Gene MDV082 Is Dispensable for Virus Replication but Contributes to a Rapid Disease Onset.
You Y; Conradie AM; Kheimar A; Bertzbach LD; Kaufer BB
J Virol; 2021 Jul; 95(15):e0013121. PubMed ID: 34011541
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of very virulent European MDV isolates.
Barrow A; Venugopal K
Acta Virol; 1999; 43(2-3):90-3. PubMed ID: 10696426
[TBL] [Abstract][Full Text] [Related]
19. Characterization of reticuloendotheliosis virus-transformed avian T-lymphoblastoid cell lines infected with Marek's disease virus.
Pratt WD; Morgan RW; Schat KA
J Virol; 1992 Dec; 66(12):7239-44. PubMed ID: 1279200
[TBL] [Abstract][Full Text] [Related]
20. Differential attenuation of Marek's disease virus-induced tumours and late-Marek's disease virus-induced immunosuppression.
Faiz NM; Cortes AL; Guy JS; Reddy SM; Gimeno IM
J Gen Virol; 2018 Jul; 99(7):927-936. PubMed ID: 29767614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
